PhRMA called on the U.S. trade representative to assess threats and barriers to intellectual property in 18 countries, and to focus in particular on China, India, Colombia, and Canada.
Source: Drug Industry Daily
PhRMA called on the U.S. trade representative to assess threats and barriers to intellectual property in 18 countries, and to focus in particular on China, India, Colombia, and Canada.
Source: Drug Industry Daily